Fulcrum Therapeutics
Price & Volume
Stats
See more52W Range | $2.86-$13.70 |
Market Cap | $207.6M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $80.8M |
Revenue Growth (YoY) | 8,990.9% |
Gross Profit (12 Mos) | $10.1M |
Diluted EPS | -$0.29 |
News
See moreYahoo Finance • 4 days ago
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
Yahoo Finance • 15 days ago
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 16 days ago
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Yahoo Finance • last year
Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences
About
CEO | Mr. Alexander C. Sapir |
Address | 26 Landsdowne Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |
